机构：[1]National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, Beijing 100050, China.[2]Peking University Clinical Research Institute, Beijing, China.[3]Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.首都医科大学附属安贞医院[4]Peking University First Hospital, Beijing, China.[5]Beijing Tiantan Hospital, Capital Medical University, Beijing, China.首都医科大学附属天坛医院[6]National Center for Cardiovascular Disease, Beijing, China.[7]School of Management and School of Economics, Tianjin Normal University, West Bin Shui Avenue, Tianjin 300074, People’s Republic of China.[8]Guangdong Research Institute for International Strategies, Guangdong University of Foreign Studies, 2 Baiyun North Avenue, Baiyun, Guangzhou, Guangdong 510420, People’s Republic of China.[9]School of International Business, Beijing Foreign Studies University, 19 North Xisanhuan Avenue Haidian, Beijing 100089, People’s Republic of China.[10]University of Newcastle, Newcastle, NSW 2308, Australia.[11]Zhongshan Hospital, Fudan University, Shanghai, China.
Background: Cardiovascular disease (CVD) is not only the primary cause of death in developed western countries, but also its disease burden is increasing in China. The purpose of constructing population cardiovascular health index is to monitor, compare and evaluate disease burden, influencing factors and prevention and control levels of Chinese population cardiovascular disease in order to provide evidence to improve population cardiovascular health. Methods: This study collected multi-source data and constructed China Cardiovascular Health Index (CHI) using literature review, questionnaire surveys, Delphi method and Analytical Hierarchy Process (AHP) model. Results: China CHI system included 52 indices of 5 dimensions, which were prevalence status of CVD, exposure of risk factors, prevention and control of risk factors, treatment situation and public health policy and service ability. The weights of 5 dimensions from high to low were successively prevention and control of risk factors 0.3656, prevalence status of CVD 0.2070, treatment situation 0.1812, public health policy and service ability 0.1458, and exposure of risk factors 0.1004. Conclusion: China CHI is a comprehensive evaluation system raised to effectively control the prevalence of CVD. In the future, we should strengthen and improve CVD monitoring and big data usage, to ensure these indices to reflect the practical situations and to become utility of controlling CVD.
基金：
National Key R&D Program of China [2017YFC1310902]
第一作者机构：[1]National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, Beijing 100050, China.
通讯作者：
通讯机构：[1]National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, Beijing 100050, China.
推荐引用方式(GB/T 7714)：
Jiang Yingying,Mao Fan,Li Yichong,et al.Construction of China cardiovascular health index[J].BMC PUBLIC HEALTH.2018,18(1):-.doi:10.1186/s12889-018-5647-7.
APA：
Jiang, Yingying,Mao, Fan,Li, Yichong,Liu, Jing,Zhang, Yan...&Zhou, Maigeng.(2018).Construction of China cardiovascular health index.BMC PUBLIC HEALTH,18,(1)
MLA：
Jiang, Yingying,et al."Construction of China cardiovascular health index".BMC PUBLIC HEALTH 18..1(2018):-
医学